0%
ICCC Series 7 - Integrated Cancer Care Conference featuring Dr. Vijay Sharnangat and leading oncology experts on 31st July 2026, 19:05 PM to 21:25 PM via Zoom.
Integrated Cancer Care Conference (ICCC) Series 7 is held on 31st July 2026 from 19:05 PM to 21:25 PM in association with Academy of Cancer Care Foundation and Research Center and Keyson Healthcare. Keynote feature on Dr. Vijay Sharnangat (MBBS, MD, DM Medical Oncology - HCG Cancer Centre, Mumbai) with 19+ years of clinical experience. Scientific sessions include: 'Recent developments in the Management of Intermediate HCC with Atezolizumab plus Bevacizumab (Roche)' by Dr. Bharat Bhosale; 'Changing treatment paradigm of Pancreatic Cancer with Nal-IRI (Servier)' by Dr. Vijay Sharnangat; 'Rational to Practice: Tislelizumab in oesophageal cancer (Glenmark)' by Dr. Anura Kantak; 'Redefining outcomes in 1L HER2+ mBC with ENHERTU + Pertuzumab (AstraZeneca)' by Dr. Rohit Pai; and panel discussion on 'Navigating the treatment options in 1st Line- Gastric, GE Junction & Esophageal Cancer (BMS)' moderated by Dr. Anup Toshniwal with panelists Dr. Rohit Pai, Dr. Jay Mehta, Dr. Aman Sondoule, Dr. Lovin Wilson. Contact Sunena (9137489482) or Priya (9988463222).
The primary aim of Integrated Cancer Care Conference Series 7 is to deliver updated, evidence-based scientific insights into gastrointestinal oncology, including advanced management strategies for colorectal, esophageal, gastric, and hepato-pancreato-biliary malignancies. The program seeks to foster multidisciplinary collaboration among clinical specialists, enhance diagnostic accuracy, and translate groundbreaking clinical trial data into daily clinical practice.
The program was conducted as a structured virtual webinar & interactive online forum. The scientific agenda comprised keynote lectures by distinguished domain experts, case-based panel discussions on complex clinical scenarios, interactive Q&A sessions, and comprehensive reviews of landmark clinical trials in Gastrointestinal Oncology.
The conference successfully equipped participating healthcare professionals with practical strategies for optimizing clinical decision-making in Gastrointestinal Oncology. By establishing updated treatment algorithms and promoting collaborative care networks, the event reinforces commitment to improving patient survival rates and quality of life.